European Respiratory Journal · 2001 · 172 citations · 25 references
MedicineClinical SciencesInternal MedicineClinical EpidemiologyPulmonary Function TestingPulmonologyCystic FibrosisLung VolumesPulmonary AssessmentPulmonary Function AssessmentPulmonary InfectionsRespiratory DiseaseAge Effects On Forced Expiratory VolumeDornase Alfa TherapyForced Expiratory Volume AssessmentForced Expiratory Volume Cutoff ValuesForced Expiratory Volume DeclineLung Function DeclineLung Function TestingPulmonary Function Decline
The European Epidemiologic Registry of Cystic Fibrosis began collecting longitudinal data on European cystic fibrosis patients in 1994. A cross-sectional analysis was performed to identify the factors associated with low values of % predicted forced expiratory volume in one second (FEV1) upon patient enrollment. Data from 7,010 patients aged > or =6 yrs were included. Clinical conditions, microbiological isolates and medications reported at enrollment or within the following 180 days were analysed for age-specific associations. Factors associated with FEV1 that were lower by >10% of pred values were: lower weight for age percentiles, haemoptysis, pneumothorax, pulmonary symptoms at presentation, Pseudomonas aeruginosa, Burkholderia cepacia, oral corticosteroids, nonsteroid anti-inflammatory drugs, dornase alfa, oxygen and assisted ventilation and, in patients >12 yrs old only, use of airway clearance techniques, inhaled bronchodilators, oral nutritional supplements, pancreatic enzymes and insulin or oral hypoglycaemics. Slightly impaired lung function (5-10%) was associated with: diabetes (> or = 18-yrs-old), gastro-oesophageal reflux, allergic bronchopulmonary aspergillosis, asthma-like symptoms, portal hypertension, Aspergillus spp. and Candida spp. Sex, Haemophilus influenzae and Staphylococcus aureus were not associated with impaired pulmonary status. Regular exercise (especially in older patients) and nasal polyposis were associated with slightly better FEV1. The results confirm those of previous studies and suggest selective prescribing in sicker patients.
25
Physical growth: National Center for Health Statistics percentiles
P V Hamill, TA Drizd, CL Johnson et al. · American Journal of Clinical Nutrition · 1979 · 2.4K citations
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
Ronald J. Knudson, M D Lebowitz, Catharine J. Holberg et al. · PubMed · 1983 · 1.9K citations
Prediction of Mortality in Patients with Cystic Fibrosis
Eitan Kerem, Joseph Reisman, Mary Corey et al. · New England Journal of Medicine · 1992 · 987 citations